Mechanism of the Valveless Pump Revealed in Online Video Presentation
|
By LabMedica International staff writers Posted on 16 Dec 2014 |
|
Image: The QG line of pumps is ideal for general laboratory and industrial use (Photo courtesy of Fluid Metering, Inc.).
The secrets behind a precision valveless pump used in both research and clinical instruments and processes have been revealed in a high definition video presentation.
Fluid Metering, Inc. (New York, USA) is a metering pumps and dispensers manufacturer, who pioneered the first patented valveless rotating and reciprocating piston metering pump concept and has been producing instruments for precise fluid control for over 55 years.
The Fluid Metering, Inc. CeramPump design utilizes a single, dimensionally stable, chemically inert ceramic piston that ensures long term, drift free fluid control. The valveless pumping function is accomplished by the synchronous rotation and reciprocation of the ceramic piston in a precisely mated ceramic cylinder liner. One complete piston revolution is required for each suction/discharge cycle. The flow rate, which can be changed while pump is operating or at rest, is easily adjusted between 0%–100% by moving the pump head position, which changes the piston stroke length and, in turn, the flow rate.
As described in a recently released on-line video presentation, the CeramPump relies on only one moving part, a rotating and reciprocating ceramic piston, to accomplish all fluid control functions without valves and will maintain a precision of 0.5% for millions of cycles without calibration or maintenance.
Related Links:
Fluid Metering, Inc.
Fluid Metering, Inc. (New York, USA) is a metering pumps and dispensers manufacturer, who pioneered the first patented valveless rotating and reciprocating piston metering pump concept and has been producing instruments for precise fluid control for over 55 years.
The Fluid Metering, Inc. CeramPump design utilizes a single, dimensionally stable, chemically inert ceramic piston that ensures long term, drift free fluid control. The valveless pumping function is accomplished by the synchronous rotation and reciprocation of the ceramic piston in a precisely mated ceramic cylinder liner. One complete piston revolution is required for each suction/discharge cycle. The flow rate, which can be changed while pump is operating or at rest, is easily adjusted between 0%–100% by moving the pump head position, which changes the piston stroke length and, in turn, the flow rate.
As described in a recently released on-line video presentation, the CeramPump relies on only one moving part, a rotating and reciprocating ceramic piston, to accomplish all fluid control functions without valves and will maintain a precision of 0.5% for millions of cycles without calibration or maintenance.
Related Links:
Fluid Metering, Inc.
New
Gold Member
Aspiration System
VACUSAFE
New
Urine Analyzer
respons® UDS100
New
Immunofluorescence Analyzer
IFA System
Latest BioResearch News
- Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
- Genetic Cause Identified for Severe Infant Epilepsy
- Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors
- Researchers Identify Survival Pathway Undermining Targeted Cancer Drugs
- Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
Channels
Clinical Chemistry
view channel
AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
Diagnosing the cause of age-related cognitive symptoms remains challenging because clinical presentations of neurodegenerative diseases often overlap, and multiple pathologies can co-occur... Read more
New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
Steroid hormone measurement is a core application of clinical mass spectrometry, which is widely regarded as a diagnostic gold standard. Access to these high-specificity methods has often been constrained... Read more
Molecular Diagnostics
view channel
RNA Profiling Uncovers Therapeutic Targets in Solid Tumors
Many patients with advanced solid tumors exhaust broad DNA panel testing yet still lack biomarkers that match guideline-recommended therapies, limiting access to targeted options. Expanding molecular profiling... Read more
Whole Genome Sequencing in Routine Care Expands Rare Disease Detection
Rare diseases often involve prolonged diagnostic journeys that delay clinical decision-making and complicate family planning. As phenotypes become more heterogeneous, sequencing-based methods are increasingly... Read more
Hematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Immunology
view channel
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microbiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read more
Pathology
view channel
AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer is typically guided by recurrence risk and population-level averages rather than patient-specific benefit. However, existing clinicopathologic... Read more
AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer remains a difficult decision because only a subset benefits and many undergo toxicity without gain. Genomic assays can help but are costly,... Read more
Technology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read more
Industry
view channel
Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation
Takara Bio USA, Inc. (San Jose, CA, USA), a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company (Reno, NV, USA) announced a development and co-marketing agreement to deliver integrated, automated... Read more
